---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-015065"
form_type: "8-K"
ticker: "FBLG"
cik: "0001958777"
company_name: "FibroBiologics, Inc."
filed_at: "2025-06-13T23:59:59+00:00"
generated_at: "2026-05-19T09:19:55.368980+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# FibroBiologics stockholders approve capital stock increase and share issuance to YA II PN

## Summary
- Authorized capital stock increased via amendment to certificate of incorporation effective June 12, 2025.
- Stockholders elected Matthew Link and Victoria Niklas, M.D. as Class II directors until 2028.
- Ratified WithumSmith+Brown, PC as independent auditor for FY 2025; votes: 53,940,908 for, 73,899 against, 528,109 abstain.
- Approved issuance of common stock to YA II PN, LTD., exceeding 7,013,635 shares under Standby Equity Purchase Agreement.
- Proxies representing 54,542,916 votes (77.4% of eligible) were present at the annual meeting.

## SEC filing metadata
- accession: 0001641172-25-015065
- form_type: 8-K
- ticker: FBLG
- cik: 0001958777
- company_name: FibroBiologics, Inc.
- filed_at: 2025-06-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1958777/000164117225015065/0001641172-25-015065-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1958777/000164117225015065/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-015065
- JSON: https://secwatch.observer/filing/0001641172-25-015065.json
- Plain text: https://secwatch.observer/filing/0001641172-25-015065.txt

## Key facts
- Governance Changes
  FibroBiologics, Inc.: The company filed an amendment to its Amended and Restated Certificate of Incorporation, effective June 12, 2025, to increase its authorized capital stock (effective 2025-06-12).
  - Change: charter amendment
  - Effective: 2025-06-12
  source text: On June 12, 2025, FibroBiologics, Inc. (the “Company”) filed with the Secretary of State of the State of Delaware an amendment to the Company’s Amended and Restated Certificate of Incorporation to increase the authorized capital stock (the “Amendment”), which became effective the same day.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1958777/000164117225015065/0001641172-25-015065-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.